Trial Profile
Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 29 Mar 2023
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 04 Apr 2022 Status changed from active, no longer recruiting to completed.
- 22 Mar 2022 Status changed from recruiting to active, no longer recruiting.
- 06 May 2021 Planned End Date changed from 31 Mar 2021 to 31 Mar 2022.